🔎 Trials Near Me

Utama › Penyakit Hati Steatotik › Missouri

Kajian klinikal Penyakit Hati Steatotik di Missouri

14 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi di Missouri.

Bandar di Missouri

Teks kajian rasmi (Bahasa Inggeris)

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • GSK Investigational Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07704892

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

  • Washington University School of Medicine, St Louis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • AMR Clinical, Kansas City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Columbia
  • Akero Clinical Study Site, Kansas City
  • Akero Clinical Study Site, St Louis
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

  • GSK Investigational Site, Springfield
  • GSK Investigational Site, St Louis
  • GSK Investigational Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

  • Gastrointestinal Associates, Columbia
  • Gateway GI Research, LLC, St Louis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, St Louis
  • 89bio Clinical Study Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

  • University of Missouri School of Medicine, Columbia
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06335771

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

  • University of Missouri School of Medicine, Columbia
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06571474

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  • GSK Investigational Site, Kansas City
  • GSK Investigational Site, Springfield
  • GSK Investigational Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  • GSK Investigational Site, Kansas City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06920043

Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

  • Harry S. Truman Memorial, Columbia, MO, Columbia
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 19 Feb 2026 · NCT05526144

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.